Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT03126084 |
Date of registration:
|
20/04/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Postoperative Effects of TAP Block Versus QLB Type 2 Block
|
Scientific title:
|
Comparison of Postoperative Analgesic Effects of Transversus Abdominis Plane Block and Quadratus Lumborum Block Type 2 |
Date of first enrolment:
|
May 2, 2017 |
Target sample size:
|
90 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03126084 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Turkey
| | | | | | | |
Contacts
|
Name:
|
Zeki T TEKGUL, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Izmir Bozyaka Training and Research Hospital |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients who are over 18 years of age
- Patients who are scheduled for elective unilateral open hernia repair with tension
free mesh techniques
- Patients who are in ASA's physical status score group 1 or 2
Exclusion Criteria:
- Patients who are younger than 18 years of age
- Patients who have severe stenotic heart diseases
- Patients who have bleeding diathesis
- Patients who have true allergies to local anesthetics
- Patients who have neurologic deficits corresponding to effect site of the anesthetic
techniques
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Postoperative Pain
|
Inguinal Hernia
|
Intervention(s)
|
Drug: 0.5% Bupivacaine+Glucose
|
Drug: 0.25% Bupivacaine
|
Drug: Tramadol HCl
|
Procedure: Inguinal Hernia Repair
|
Drug: Acetaminophen
|
Primary Outcome(s)
|
Pain Intensity
[Time Frame: 2 hours after surgery]
|
Pain Intensity
[Time Frame: 24 hours after surgery]
|
Pain Intensity
[Time Frame: 6 hours after surgery]
|
Pain Intensity
[Time Frame: 48 hours after surgery]
|
Secondary ID(s)
|
ANES-QLB-0609
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|